• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Blue Water Acquisition Corp. III Announces the Upsized Pricing of $220 Million Initial Public Offering

    6/10/25 6:00:00 AM ET
    $BLUWU
    Business Services
    Finance
    Get the next $BLUWU alert in real time by email

    GREENWICH, Conn., June 10, 2025 /PRNewswire/ -- Blue Water Acquisition Corp. III (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by Chairman and Chief Executive Officer Joseph Hernandez, today announced the upsized pricing of its initial public offering of 22,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. The units are expected to trade on The Nasdaq Global Market ("Nasdaq")under the ticker symbol "BLUWU" beginning on June 10, 2025. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols "BLUW" and "BLUWW," respectively.

    Blue Water Acquisition Corp iii logo

    BTIG, LLC is acting as sole book-running manager for the offering.

    The Company has granted the underwriter a 45-day option to purchase up to an additional 3,300,000 units at the initial public offering price to cover over-allotments, if any. The offering is expected to close on June 11, 2025, subject to customary closing conditions.

    A registration statement relating to the securities sold in the initial public offering was declared effective by the U.S. Securities and Exchange Commission (the "SEC") on June 9, 2025. The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from: BTIG, LLC, 65 East 55th Street, New York, New York 10022, or by email at [email protected], or by accessing the SEC's website at www.sec.gov.

    This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    About Blue Water Acquisition Corp. III

    Blue Water Acquisition Corp. III is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, the Company intends to focus on high-potential companies in the artificial intelligence (AI), biotechnology, healthcare and technology sectors.

    Forward-Looking Statements

    This press release contains statements that constitute "forward-looking statements," including with respect to the Company's initial public offering and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the Company's initial public offering filed with the SEC. Copies are available on the SEC's website,www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this press release, except as required by law.

    Contact:

    Stephanie Mercier

    15 E. Putnam Avenue, Suite 363

    Greenwich, CT 06830

    [email protected] 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/blue-water-acquisition-corp-iii-announces-the-upsized-pricing-of-220-million-initial-public-offering-302477150.html

    SOURCE Blue Water Acquisition Corp iii

    Get the next $BLUWU alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLUWU

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BLUWU
    SEC Filings

    See more
    • SEC Form EFFECT filed by Blue Water Acquisition Corp.

      EFFECT - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

      10/8/21 12:15:18 AM ET
      $BLUWU
      Business Services
      Finance
    • SEC Form 424B3 filed by Blue Water Acquisition Corp.

      424B3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

      10/7/21 5:07:36 PM ET
      $BLUWU
      Business Services
      Finance
    • SEC Form S-1 filed by Blue Water Acquisition Corp.

      S-1 - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

      9/30/21 4:07:33 PM ET
      $BLUWU
      Business Services
      Finance

    $BLUWU
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Blue Water Acquisition Corp. III Announces Closing of Upsized $253 Million Initial Public Offering

      GREENWICH, Conn., June 11, 2025 /PRNewswire/ -- Blue Water Acquisition Corp. III (the "Company") (NASDAQ:BLUWU), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by Chairman and Chief Executive Officer Joseph Hernandez, today announced the closing of its upsized initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option, at an offering price of $10.00 per unit, resulting in gross proceeds of $253,000,000. The Company'

      6/11/25 1:24:00 PM ET
      $BLUWU
      Business Services
      Finance
    • Blue Water Acquisition Corp. III Announces the Upsized Pricing of $220 Million Initial Public Offering

      GREENWICH, Conn., June 10, 2025 /PRNewswire/ -- Blue Water Acquisition Corp. III (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by Chairman and Chief Executive Officer Joseph Hernandez, today announced the upsized pricing of its initial public offering of 22,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. The units are expected to trade on The Nasdaq Global Market ("Nasdaq")under the ticker symbo

      6/10/25 6:00:00 AM ET
      $BLUWU
      Business Services
      Finance
    • Blue Water Acquisition Corp. Announces Stockholder Approval of Business Combination with Clarus Therapeutics, Inc.

      GREENWICH, Conn., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ:BLUW), a special purpose acquisition company ("Blue Water"), today announced that its stockholders have voted to approve the proposed business combination (the "Business Combination") with Clarus Therapeutics, Inc., a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women ("Clarus") at its special meeting of stockholders (the "Special Meeting") held today, August 27, 2021. Holders of approximately 73.95% of Blue Water's issued and outstanding shares cast votes at the Special Meeting. Approximately 69.57% o

      8/27/21 12:58:37 PM ET
      $BLUW
      $BLUWU
      Business Services
      Finance

    $BLUWU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: H.I.G. Ventures - Clarus, Llc was granted 5,692,381 shares

      4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

      10/4/21 4:09:50 PM ET
      $BLUWU
      Business Services
      Finance
    • SEC Form 3 filed by new insider H.I.G. Ventures - Clarus, Llc

      3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

      10/4/21 4:07:54 PM ET
      $BLUWU
      Business Services
      Finance
    • SEC Form 3: New insider Cbc Spvi Ltd claimed ownership of 3,602,287 units of Common Stock

      3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)

      9/24/21 6:05:09 AM ET
      $BLUWU
      Business Services
      Finance

    $BLUWU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Blue Water Acquisition Corp. (Amendment)

      SC 13G/A - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)

      10/8/21 4:24:24 PM ET
      $BLUWU
      Business Services
      Finance
    • SEC Form SC 13G filed by Blue Water Acquisition Corp.

      SC 13G - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)

      9/24/21 6:06:39 AM ET
      $BLUWU
      Business Services
      Finance
    • SEC Form SC 13D filed by Blue Water Acquisition Corp.

      SC 13D - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)

      9/21/21 4:18:31 PM ET
      $BLUWU
      Business Services
      Finance